PHILLIPS T DANNY 4
4 · Caris Life Sciences, Inc. · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Caris Life Sciences Director T. Danny Phillips Receives 3,739-Share Award
What Happened
T. Danny Phillips, a director of Caris Life Sciences (CAI), was issued 3,739 shares on 2026-02-26 as an award/compensation (transaction code A). The shares were valued at $20.06 each, for a total reported value of $75,004. This issuance was compensation (shares issued in lieu of cash retainer fees), not an open-market purchase or sale.
Key Details
- Transaction date and price: 2026-02-26 at $20.06 per share; total value $75,004.
- Transaction type: Award/Grant (code A) — shares issued in lieu of 2025 board retainer cash fees.
- Method: Number of shares was calculated by dividing the cash retainer by the ten-trading-day VWAP through and including Feb 25, 2026 (per footnote).
- Shares owned after transaction: Not disclosed in the provided filing.
- Filing date: Report filed 2026-02-27 for the 2026-02-26 transaction — no late filing indicated.
Context
This was a compensation issuance rather than a purchase or sale. Shares issued in lieu of cash do not necessarily signal the insider’s view of the company’s stock — they reflect routine director compensation.
Insider Transaction Report
Form 4
PHILLIPS T DANNY
Director
Transactions
- Award
Common Stock
[F1]2026-02-26$20.06/sh+3,739$75,004→ 119,868 total
Footnotes (1)
- [F1]Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026.
Signature
/s/ J. Russel Denton, Attorney-in-Fact|2026-02-27